CASI Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VR ADVISER, LLC | 11/14/2025 | 987.26 K | $1.64 M | 0.00% | 6.37% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 11/14/2025 | 979.96 K | $1.63 M | 24.50% | 6.32% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 254.88 K | $423.11 K | 2,013.29% | 1.64% |
| WOODLINE PARTNERS LP | 11/14/2025 | 165.64 K | $274.96 K | 0.00% | 1.07% |
| WELLINGTON SHIELDS CAPITAL MANAGEMENT, LLC | 11/05/2025 | 69.54 K | $115.43 K | -23.46% | 0.45% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 43.90 K | $72.87 K | 11.99% | 0.28% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 33.27 K | $55.22 K | 100.00% | 0.21% |
| WELLINGTON SHIELDS & CO., LLC | 11/05/2025 | 30.09 K | $49.95 K | 0.00% | 0.19% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 18.81 K | $31.22 K | 0.00% | 0.12% |
| GROUND SWELL CAPITAL, LLC | 11/06/2025 | 10.14 K | $16.82 K | 100.00% | 0.07% |
| ROYAL BANK OF CANADA | 11/14/2025 | 9.95 K | $16.00 K | 0.00% | 0.06% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 2.30 K | $3.82 K | 100.00% | 0.01% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 505 | $838 | 0.00% | 0.00% |
| MORGAN STANLEY | 11/14/2025 | 365 | $606 | 0.00% | 0.00% |
| BLACKROCK, INC. | 11/12/2025 | 296 | $491 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 134 | $222 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 25 | $42 | 0.00% | 0.00% |
| UBS GROUP AG | 11/13/2025 | 14 | $23 | -98.53% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/14/2025 | 13 | $22 | 0.00% | 0.00% |
| COLONIAL TRUST CO / SC | 11/10/2025 | 11 | $18 | 0.00% | 0.00% |
| MAI CAPITAL MANAGEMENT | 11/10/2025 | 5 | $9 | 0.00% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CASI Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 26 institutional investors and hedge funds held shares of CASI Pharmaceuticals, Inc.. The most heavily invested institutionals were:
VR Adviser, LLC: 987,259
Foresite Capital Management VI LLC: 979,956
BANK OF AMERICA CORP /DE/: 254,884
Woodline Partners LP: 165,640
Wellington Shields Capital Management, LLC: 69,535
RENAISSANCE TECHNOLOGIES LLC: 43,900
16.81% of CASI Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.61 M shares in the last 24 months. This purchase volume represents approximately $4.82 M in transactions.